Cookie Consent by PrivacyPolicies.com


Frontiers in Kidney Medicine and Biology

Frontiers in Kidney Medicine and Biology is an interview series presented by the Renal Research Institute (RRI) and hosted by Peter Kotanko, MD, FASN and Research Director at RRI. Each episode of the Frontiers in Kidney Medicine and Biology series showcases an in-depth conversation with thought leaders from around the world. These foremost scientists and doctors share their insights into the latest advances in renal research and beyond, and share how they are taking medicine, research and science to exponentially higher levels. Each episode of Frontiers in Kidney Medicine and Biology series is available on the RRI YouTube channel, and podcasts on Spotify, Apple Music, or wherever you listen to your podcasts.

View YouTube Channel Listen on spotify

CME Information

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nursing Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Chosen sessions must be reviewed in their entirety. Partial credit of individual sessions is not available. If learners are seeking continuing education credit for a specialty not listed below, it is their responsibility to contact the licensing/ certification board to determine course eligibility for their specific licensing/certification requirement.

Credit Designation Statement

Enduring Content:

Amedco LLC designates the enduring material activity portion for a maximum of 6.0 (.50 for each episode) AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activities.

Other Health Care Professionals:

Other health care professionals who participate in this CME activity may submit this statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. Participants are responsible for determining whether this activity meets the requirements for acceptable continuing education.

Acknowledgment of Financial Commercial Support:

No financial commercial support was received for this educational activity.

Acknowledgment of In-Kind Commcercial Support:

No in-kind commercial support was received for this educational activity.

Learning Objectives


After participating in this activity, the participant will be better able to demonstrate how to:

  • Identify sound grasp of novel developments in kidney medicine and biology and apply them in clinical practice.
  • Assess how to apply precision medicine tools in patient care.
  • Evaluate new developments in kidney medicine and biology and assess them for applicability in clinical medicine.

Episodes

Displaying 5 articles
  • Sep 22, 2021

    A fresh look at an old problem: renal anemia

    In this episode, Dr. Peter Kotanko is joined by Dr. Roberto Pecoit-Filho, Senior Research Scientist from the Arbor Research Collaborative for Health, to discuss the differences between anemia in the general population and in patients with kidney disease. We also discuss the current understanding of the mechanisms behind CKD anemia and the perspective of the introduction of new treatment options and an expansion in the understanding of the pathophysiology.
  • Aug 25, 2021

    Creatinine: old molecule, new insights.

    In this session join Drs. Peter Kotanko and Bernard Canaud discuss the suggestion that monthly monitoring of SCI, as part of routine baseline dialysis patient monitoring, will offer a new and cost-effective tool to detect earlier nutritional status deterioration. SCI used as a surrogate marker of active MM would facilitate detection of sarcopenia trends, offering opportunities to implement interventions that might delay, and halt or even reverse such deleterious dynamics. SCI can be easily integrated and used as a first-line tool in complement to visceral proteins (i.e., albumin) to monitor muscle mass changes in clinical routine
  • Jul 28, 2021

    From dialysis to Mount Everest and back

    In this session, the pathophysiology of hypoxemia and hypoxia in patients on dialysis will be discussed, as well as the mechanisms by which these phenomena are related to adverse outcomes. The maladaptive responses in patients on dialysis will be discussed in the context of comparative physiology, with the example of Sherpa, which shows a highly adaptive response to ambient hypoxia. It will also be discussed how lessons from comparative physiology might be of potential benefit to patients on dialysis.
  • Jun 23, 2021

    Hemodialysis: the thrice weekly challenge

    This session discusses my research interests in general and particularly a piece of research that aimed to describe the time of onset of intradialytic hypotension during hemodialysis sessions.
  • May 26, 2021

    UV light: friend or foe?

    A discussion between Drs. Peter Kotanko and Richard Weller on the latter’s research into the effects of sunlight on systemic health. Dr. Weller describes two recent epidemiological studies he has performed in which he demonstrated an inverse relationship between sunlight exposure and blood pressure, and COVID mortality. He has previously demonstrated NO release from UV exposed skin to the circulation which may account for these effects.